Stanford University
Showing 1,231-1,240 of 5,039 Results
-
Brady Evans, MD, MBA
Clinical Assistant Professor, Orthopaedic Surgery
Clinical Assistant Professor (By courtesy), Surgery - Plastic & Reconstructive SurgeryBioDr. Evans is an orthopaedic surgeon and a clinical assistant professor of orthopaedic surgery specializing in the treatment of hand and upper extremity conditions. He has extensive training in the full range of orthopaedic treatment approaches, from noninvasive strategies to the most advanced surgical procedures, including peripheral nerve and microvascular surgery.
Among the wide spectrum of conditions that Dr. Evans treats are joint, ligament, and tendon injuries; nerve and vessel disorders; all forms of arthritis; fractures; carpal and cubital tunnel syndrome; and, pediatric and congenital disorders of the hands and upper extremities.
Implementing a comprehensive patient treatment plan usually involves multiple specialists. Dr. Evans collaborates with other team members such as spinal care specialists, rheumatologists, plastic surgeons, and physical and occupational therapists. He also closely coordinates treatment and follow-up with the primary care physicians and emergency medicine physicians, as well as other orthopaedic specialists, who refer patients for his specialized care.
For every patient he sees, he develops a personalized plan of care emphasizing the most conservative treatment possible. The goal of each patient’s care plan is to precisely diagnose the condition, relieve symptoms that may include pain and immobility, and restore use of the affected hand or limb as safely and quickly as possible.
The opportunity to treat diverse, complex conditions from start to finish and help patients return to functionality and mobility are among the key reasons Dr. Evans chose to practice orthopaedic surgery. To help advance his specialty through innovative research initiatives, Dr. Evans has investigated applications of frontier technology such as virtual reality and artificial intelligence to enhance patient care and education. His research interests also include the management of distal radius fractures, surgical decision-making, and costs and outcomes of orthopaedic surgical procedures.
As an author, Dr. Evans has published articles in numerous journals including the Journal of Bone and Joint Surgery, Journal of Pediatric Orthopaedics, Archives of Surgery, Current Reviews in Musculoskeletal Medicine, and others. Article topics range from clinical issues to the financial aspects of care. He also has contributed textbook chapters as the primary author of “Fractures of the Distal Radius and Ulna” in Rockwood and Green’s Fractures in Adults, 9th edition and as an author of “Carpal Tunnel Syndrome After Fractures and Other Trauma” in the 2017 edition of the guide Carpal Tunnel Syndrome. In addition, he is a reviewer for HAND, the official journal of the American Association for Hand Surgery, and for the Journal of Hand Surgery Global Online.
Dr. Evans makes scientific presentations at major national conferences on a variety of topics: resident education, virtual reality in health care, plus various aspects of clinical care.
He has won honors and recognition for his research and scholarship, including the Richard J. Smith Award from Massachusetts General Hospital and Harvard Medical School for the best clinical/translational paper presentation.
Dr. Evans is board-eligible with the American Board of Orthopaedic Surgery and a member of the American Academy of Orthopaedic Surgeons and American Society for Surgery of the Hand. -
Stephanie Allen Evans
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioResume visible at http://bit.ly/EvansResume
This link needs to be copied and pasted into your browser to view. -
Robert Michael Fairchild
Assistant Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsDr. Fairchild’s research focuses on musculoskeletal and organ-based ultrasound in rheumatic disease, including arthritis, calcinosis, vascular pathology, and interstitial lung disease. He develops ultrasound-based outcome measures and leads projects applying deep learning and explainable AI to imaging. He also performs ultrasound-guided synovial biopsies to support translational and clinical research.
-
Bita Fakhri, MD, MPH
Associate Professor of Medicine (Hematology)
BioDr. Bita Fakhri is an Associate Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. She specializes in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), hairy cell leukemia, Richter’s syndrome, and other hematologic malignancies.
As a clinical scientist, Dr. Fakhri is dedicated to patient care, trainee education, and the development of novel therapies for individuals with CLL/SLL. She has co-authored numerous publications focusing on CLL, targeted therapies, and cellular therapies in hematologic malignancies.
Dr. Fakhri currently serves as Director of the CLL Clinical Trial Portfolio at Stanford. In addition, she is actively involved in building infrastructure to expand access to clinical trials and promote equity in care for underserved and marginalized populations across the Stanford catchment area. -
Titilola Falasinnu
Assistant Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
BioI am primarily a lupus researcher and identify as a pain scientist and methodologist in this field. Systemic lupus erythematosus (SLE) disproportionately affects women and racial minorities and is the fifth most common cause of death among 15- to 24-year-old Black and Hispanic women in the U.S., highlighting its significant public health impact. More than half of patients with SLE experience chronic pain, often secondary to SLE itself or overlapping conditions (e.g., migraines, low back pain, fibromyalgia), contributing significantly to disability and impaired quality of life. Chronic pain is not merely a symptom but a disease in its own right—one that deserves the same rigorous study and clinical attention as comorbidities like kidney disease and cardiovascular disease in rheumatology. The enormous global burden of chronic pain underscores the urgent need for a clear, standardized definition of pain as a disease, particularly in autoimmune rheumatic diseases where pain can arise from inflammatory, nociplastic, and biopsychosocial mechanisms. Without recognizing pain as a distinct disease entity, its mechanisms remain poorly understood, and effective treatment strategies remain underdeveloped.
I am a co-Principal Investigator of the Pain Intelligence Lab, where our mission is to advance the study of pain as a disease in rheumatology through two primary objectives. First, we develop and validate computational methods that enable clinicians and researchers to leverage electronic health records, administrative claims, and disease registries to study chronic pain as a distinct disease entity in rheumatology. By applying machine learning, natural language processing, and real-world data analysis, we seek to enhance pain phenotyping, classify distinct pain subtypes, and develop predictive models for treatment response. Second, we use a biopsychosocial framework to examine the predictive power of biomarkers and psychosocial measures in rheumatologic pain. By integrating biological, psychological, and social determinants of pain, we aim to conduct rigorous, patient-oriented research that translates targeted assessments into mechanistically informed, personalized treatment approaches for optimized clinical care. Ultimately, my long term career goal is to bridge the gap between research and clinical practice, ensuring that pain management in autoimmune rheumatic diseases is precise, equitable, and optimized for improved patient outcomes.
